PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
0.99
0.02 (1.96%)
At close: Sep 26, 2025, 3:01 PM
0.97
-2.41%
After-hours: Sep 26, 2025, 04:00 PM EDT
1.96% (1D)
| Bid | 0.69 |
| Market Cap | 6.76M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.13M |
| EPS (ttm) | 0.06 |
| PE Ratio (ttm) | 16.57 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.26 |
| Volume | 29,171 |
| Avg. Volume (20D) | 90,763 |
| Open | 0.98 |
| Previous Close | 0.97 |
| Day's Range | 0.96 - 0.99 |
| 52-Week Range | 0.80 - 2.42 |
| Beta | -0.24 |
| Ex-Dividend Date | n/a |
About PMCB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PMCB
Website n/a
1 month ago · businesswire.com
PharmaCyte Biotech, Inc. Announces Closing of $7 Million FinancingLAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, ...
